CHD8 Gene

CHD8 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CHD8 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CHD8</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CHD8</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=CHD8" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

CHD8 (Chromodomain Helicase DNA Binding Protein 8, NCBI Gene ID: 57680, OMIM: 610527, UniProt: [Q9HCK8](https://www.uniprot.org/uniprot/Q9HCK8)) is a critical ATP-dependent chromatin remodeling factor and transcriptional regulator. As one of the largest members of the CHD (Chromodomain Helicase DNA-binding) family, CHD8 plays essential roles in neurodevelopment, Wnt/β-catenin signaling, and chromatin architecture maintenance. Heterozygous loss-of-function mutations in CHD8 are among the most common genetic causes of autism spectrum disorder (ASD), accounting for approximately 0.2% of all cases[@bernier2014]. Beyond its well-established role in neurodevelopmental disorders, emerging research suggests CHD8 dysfunction may contribute to neurodegenerative processes through epigenetic dysregulation, altered chromatin states, and impaired neuronal survival mechanisms[@plummer2023].

CHD8 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CHD8 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CHD8</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CHD8</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=CHD8" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

CHD8 (Chromodomain Helicase DNA Binding Protein 8, NCBI Gene ID: 57680, OMIM: 610527, UniProt: [Q9HCK8](https://www.uniprot.org/uniprot/Q9HCK8)) is a critical ATP-dependent chromatin remodeling factor and transcriptional regulator. As one of the largest members of the CHD (Chromodomain Helicase DNA-binding) family, CHD8 plays essential roles in neurodevelopment, Wnt/β-catenin signaling, and chromatin architecture maintenance. Heterozygous loss-of-function mutations in CHD8 are among the most common genetic causes of autism spectrum disorder (ASD), accounting for approximately 0.2% of all cases[@bernier2014]. Beyond its well-established role in neurodevelopmental disorders, emerging research suggests CHD8 dysfunction may contribute to neurodegenerative processes through epigenetic dysregulation, altered chromatin states, and impaired neuronal survival mechanisms[@plummer2023].

CHD8 functions by recruiting β-catenin (CTNNB1) to Wnt target gene promoters, thereby modulating the transcriptional programs that govern neural progenitor proliferation, cortical layer formation, and synaptic development[@katayama2016]. Its ability to reshape chromatin landscape affects hundreds of downstream targets including cell cycle regulators, synaptic proteins, and neurodevelopmental transcription factors[@noh2017].

Gene Structure and Protein Architecture

Genomic Organization

The human CHD8 gene spans approximately 197 kb on chromosome 14q11.2 and contains 37 coding exons. The gene encodes a 2,563 amino acid protein with a molecular weight of approximately 285 kDa. CHD8 is highly conserved across vertebrates, with orthologs in mouse (Chd8), zebrafish, and Drosophila.

Domain Architecture

CHD8 protein contains several distinct functional domains:

• Tandem chromodomains (amino acids 1-200): Two N-terminal chromodomains that bind methylated histone tails, particularly H3K4me0 and H3K9me3. These domains target CHD8 to specific chromatin regions.
• Snf2-like ATPase domain (amino acids 500-700): The central helicase domain that provides ATP-dependent chromatin remodeling activity. This domain belongs to the SWI/SNF2 family and hydrolyzes ATP to slide, eject, or restructure nucleosomes.
• DNA-binding domain (amino acids 750-900): Facilitates interaction with DNA during chromatin remodeling.
• BRK domain (amino acids 1850-1920): Present in some CHD family members, may mediate protein-protein interactions.
• C-terminal region: Contains glutamine-rich regions and potential transcriptional activation domains.

Transcript Variants

Multiple CHD8 transcript variants have been documented:

• Isoform 1 (canonical): Full-length 2,563 aa protein
• Shorter isoforms: Truncated variants expressed in specific tissues

Molecular Functions

Chromatin Remodeling Activity

CHD8 remodels chromatin through ATP-dependent nucleosome sliding and restructuring[@cotney2015]. Unlike many SWI/SNF family members, CHD8 shows particular specificity for:

• Nucleosome positioning: Shifting nucleosomes to alter transcription factor accessibility
• Chromatin decompaction: Reducing chromatin compaction to enable transcriptional activation
• Histone eviction: Facilitating removal of nucleosomes from specific genomic regions

Transcriptional Regulation

CHD8 functions as both a direct chromatin remodeler and a transcriptional co-activator. Key mechanisms include:

Beta-catenin recruitment: CHD8 binds directly to β-catenin through a C-terminal domain and recruits it to Wnt target gene promoters[@katayama2016]. This interaction is critical for:

• Transcriptional activation of Wnt-responsive genes
• Modulation of neural progenitor cell cycle
• Regulation of cortical brain size

• Promoter-proximal pausing release
• Co-transcriptional histone modification
• mRNA processing and splicing

Key Target Pathways

CHD8 directly regulates an extensive network of downstream targets:

Wnt/β-catenin signaling cascade:

• CTNNB1 (β-catenin itself)
• LEF1, TCF7 (transcription factors)
• AXIN2 (negative regulator)
• MYC, CCND1 (cell cycle targets)

• CDK6, CDK4 (cyclin-dependent kinases)
• CCND1, CCND2 (cyclins)
• MCM family (DNA replication)

• NEUROD1, ASCL1 (proneural transcription factors)
• RELN (reelin signaling)
• GLI3 (Shh pathway effector)
• GAD1, SLC6A1 (synaptic proteins)

• GRIN family (NMDA receptor subunits)
• GRIK family (AMPA receptor subunits)
• DLG4 (PSD-95)
• SYN1, SYN2 (synapsins)

Brain Expression and Localization

Developmental Expression

CHD8 exhibits dynamic expression patterns during brain development:

• Embryonic stage: High expression in neural tube and cortical ventricular zone
• Mid-gestation: Peak expression in neural progenitor populations
• Late gestation: Expression shifts to post-mitotic neurons in cortical plate

Regional Distribution in Adult Brain

Based on human brain atlas data and animal studies:

• Cerebral cortex: Highest expression in layer 2/3 pyramidal neurons, moderate in layer 5/6
• Hippocampus: Strong expression in dentate gyrus granule cells and CA3 pyramidal neurons
• Cerebellum: High expression in Purkinje cells
• Striatum: Moderate expression in medium spiny neurons
• Substantia nigra: Lower expression in dopaminergic neurons

Subcellular Localization

CHD8 localizes primarily to the nucleus where it:

• Associates with open chromatin regions
• Colocalizes with RNA Pol II at active promoters
• Binds to enhancers marked by H3K27ac

Disease Associations

Autism Spectrum Disorder (ASD)

CHD8 is one of the most penetrant ASD risk genes identified to date[@bernier2014].

Mutation spectrum:

• Predominantly de novo loss-of-function variants (nonsense, frameshift, splice site)
• Missense mutations primarily affect ATPase and chromodomain regions
• No clear hotspot — mutations distributed across the coding sequence

• Macrocephaly (head circumference >97th percentile)
• Distinctive facial features (broad forehead, hypertelorism, flat midface)
• Intellectual disability (IQ range 40-85, average ~70)
• Gastrointestinal dysfunction (constipation, constipation-predominant IBS)
• Sleep disturbances (insomnia, irregular sleep patterns)
• Hypotonia and joint laxity
• Strong male predominance (4:1)

• Neural progenitor proliferation timing
• Cortical layer formation and neuronal migration
• Synaptic development and plasticity
• Wnt-dependent brain growth trajectories

Schizophrenia and Psychosis

Emerging evidence links CHD8 to schizophrenia risk:

• Rare deleterious variants found in schizophrenia cohorts
• Dysregulated Wnt signaling shares pathways with other schizophrenia risk genes
• Common polygenic overlap with ASD and intellectual disability

Alzheimer's Disease and Neurodegeneration

While CHD8 is not a classical Alzheimer's disease gene, several lines of evidence suggest potential roles:

Epigenetic dysregulation in AD: CHD8-mediated chromatin remodeling is among the pathways disrupted in AD brains. Loss of normal chromatin regulation contributes to:

• Altered expression of synaptic genes
• Dysregulated inflammatory responses
• Impaired neuronal resilience

• Promotes neurogenesis and synaptic maintenance
• Provides anti-apoptotic protection
• Modulates amyloid processing

• Global DNA hypomethylation
• Site-specific hypermethylation at neuronal genes
• Altered histone modification patterns

Neurodevelopmental Delay (Non-ASD)

Beyond ASD, CHD8 mutations cause:

• Global developmental delay
• Speech and language impairment (often the most affected domain)
• Motor developmental delays
• Adaptive functioning deficits

Molecular Mechanisms

Wnt/β-Catenin Signaling Dysregulation

CHD8 modulation of the Wnt pathway represents its most studied disease mechanism[@katayama2016].

Normal function: Under basal conditions, β-catenin is sequestered in a destruction complex (APC, AXIN1/2, GSK3B, CK1α). Wnt ligand binding stabilizes β-catenin, allowing it to translocate to the nucleus and co-activate transcription with TCF/LEF factors. CHD8 facilitates β-catenin recruitment to chromatin at Wnt target genes.

In CHD8 haploinsufficiency:

• Reduced β-catenin recruitment to chromatin
• Decreased Wnt target gene activation
• Altered neural progenitor proliferation rates
• Brain growth dysregulation (often leading to macrocephaly as a compensatory mechanism)

Chromatin State Alterations

CHD8 mutations cause widespread chromatin accessibility changes[@wilson2019]:

• Opening of closed chromatin: Unexpectedly, loss of CHD8 leads to chromatin decompaction at some loci, suggesting its normal role includes repressing certain enhancers.
• Compensatory chromatin remodeling: Other SWI/SNF family members (including CHD7) may partially compensate, leading to tissue-specific phenotypes.
• Developmental stage specificity: Effects are most pronounced during critical developmental windows when CHD8 is most highly expressed.

Interaction Networks

CHD8 protein-protein interactions include:

• CTNNB1 (β-catenin): Direct physical interaction via C-terminal domain
• GLI3: Regulates GLI3 processing and Shh pathway cross-talk
• REST: Co-repressor complex recruitment
• CTCF: Insulator function and chromatin looping
• RNA Pol II: Direct interaction for transcriptional co-activation
• HDAC1/2: Histone deacetylase recruitment for chromatin modulation

Therapeutic Implications

Small Molecule Approaches

Wnt pathway modulators: Given the central role of Wnt dysregulation in CHD8-related disorders:

• Wnt agonists (small molecules activating β-catenin transcriptional activity) are under investigation
• GSK3B inhibitors (e.g., tideglusib) modulate downstream Wnt targets
• Targeting specific time windows during development is critical

• HDAC inhibitors may modulate downstream chromatin effects
• Bromodomain inhibitors (BET inhibitors) targeting readers of acetylated chromatin
• DNA methyltransferase inhibitors for global epigenetic correction

Gene Therapy Potential

• AAV-mediated CHD8 expression represents a potential therapeutic approach
• Delivery to critical brain regions during development windows
• Must balance expression levels — both haploinsufficiency and overexpression cause problems

Clinical Management

Current management focuses on symptomatic treatment:

• Behavioral interventions for ASD features
• GI management for constipation
• Sleep hygiene and pharmacological aids
• Early developmental support and education

Animal Models

Mouse Models

Chd8 haploinsufficiency mice:

• Recapitulate macrocephaly phenotype
• Show social behavior deficits
• Display learning and memory impairments
• exhibit abnormal cortical development
• Gene expression changes mirror human patient findings

• Forebrain-specific knockout reproduces cortical phenotypes
• Neural progenitor-specific knockout affects proliferation

Zebrafish Models

chd8 morpholino knockdowns cause:

• Craniofacial abnormalities
• Head size reduction
• Microcephaly (contrasting with mammalian macrocephaly — possibly due to different developmental timing)

Prognostic and Diagnostic Value

Genetic Testing

CHD8 should be included in:

• ASD gene panels (often tier 1)
• Intellectual disability gene panels
• Macrocephaly-associated gene panels
• Chromatin remodeling gene panels

Variant Interpretation

• Loss-of-function variants in coding exons are considered pathogenic
• Missense variants require functional studies for interpretation
• 3' truncating variants may represent benign variants (alternative isoform usage)

See Also

• [Chromatin Remodeling](/mechanisms/chromatin-remodeling) — broader context of chromatin factors in neurodegeneration
• [Wnt Signaling Pathway](/mechanisms/wnt-signaling-pathway) — Wnt pathway mechanisms
• [CTNNB1 Gene](/entities/ctnnb1) — β-catenin, direct interactor
• [CHD7 Gene](/genes/chd7) — related chromatin remodeler
• [Autism Spectrum Disorder](/diseases/autism-spectrum-disorder) — ASD phenotype
• [Alzheimer's Disease](/diseases/alzheimers-disease) — neurodegenerative context
• [Epigenetics in Neurodegeneration](/mechanisms/epigenetics-neurodegeneration) — chromatin-based mechanisms

External Links

• [NCBI Gene 57680](https://www.ncbi.nlm.nih.gov/gene/57680)
• [OMIM 610527](https://www.omim.org/entry/610527)
• [UniProt Q9HCK8](https://www.uniprot.org/uniprot/Q9HCK8)
• [Ensembl ENSG00000100888](https://www.ensembl.org/Human/Gene/Summary?g=ENSG00000100888)
• [GeneCards CHD8](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CHD8)